Global Marburg Virus Disease Therapeutics Market Projected to Reach USD 155 Million by 2033 at a 5.5% CAGR

Global Marburg Virus Disease Therapeutics Market

The global Marburg Virus Disease Therapeutics Market is anticipated to achieve a market value of USD 90.74 million in 2023, with projections indicating growth to USD 155 million by 2033. This represents a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2023 to 2033.

The growth of the Marburg virus disease therapeutics market is primarily driven by the increasing prevalence of the Marburg virus across various geographical regions. As healthcare systems recognize the critical need for effective treatments and therapeutics, demand for Marburg virus disease therapeutics has demonstrated a CAGR of 4.1% during the historical period from 2018 to 2022.

Key Market Insights:

• Projected Market Value for 2023: US$ 90.74 million
• Anticipated Market Value by 2033: US$ 155 million
• CAGR (2023-2033): 5.5%
• Historical CAGR (2018-2022): 4.1%

The rising incidence of Marburg virus disease, particularly in endemic regions, underscores the urgent need for effective therapeutic interventions. This growing demand is prompting pharmaceutical companies and research institutions to invest in the development of innovative therapies to combat this severe viral infection.

As the global healthcare community mobilizes to address the challenges posed by emerging viral threats, the Marburg virus disease therapeutics market is expected to expand significantly. Continued research and development efforts, coupled with increasing awareness of the disease, will further enhance the market’s growth potential over the coming decade.

iddle East and Africa along with North America are the two major reasons contributing to the growth of the Marburg virus diseases therapeutics market. This is owing to the increasing cases of Marburg virus in Middle East and Africa whereas on the other hand, the strong presence of key players in North America is investing in research and development for Marburg virus diseases therapeutics.

Key Takeaways from the Market Study

• The hospitals segment is expected to hold 45% of the market share in 2023 for Marburg virus disease therapeutics market.
• The Marburg virus disease therapeutics market is expected to grow at a value of 5.5% CAGR for forecast period 2023-2033.
• North America is expected to possess 43% market share for Marburg virus disease therapeutics market in 2023.
• Asia Pacific Marburg virus disease therapeutics market size is expected to possess 39% market share in 2023.

“The increasing prevalence of Marburg virus disease along with investment in efforts for research and development for innovating therapeutics is creating lucrative opportunities for the market,”states an FMI analyst.

Market Competition

Key players in the Marburg virus disease therapeutics market are Amicus Therapeutics, Inc, Alexion Pharmaceuticals, Inc, BioCryst Pharmaceuticals, Bavarian Nordic, Bio-Rad Laboratories, Inc, AlphaVax, GW Pharmaceuticals plc, Takeda Pharmaceutical Company Limited, Alexion Pharmaceuticals, Inc, Mapp Biopharmaceutical, Collaborations Pharmaceuticals, Inc, Emergent BioSolutions Inc, BioMarin and Sarepta Therapeutics, Alkido Pharma, Biofactura

• BioCryst Pharmaceuticals, a key player in the Marburg virus disease therapeutics market is focusing on undertaking research and development for understanding the nature of the virus and innovating therapeutic treatments for the same.
• Bio-Rad Laboratories, Inc, another key player in the Marburg virus disease therapeutics market is integrating technology to understand the ailment and offering medication for treating the virus.

Key Companies Profiled

• Amicus Therapeutics Inc.
• Alexion Pharmaceuticals Inc.
• BioCryst Pharmaceuticals
• Bavarian Nordic
• Bio-Rad Laboratories, Inc.
• AlphaVax
• GW Pharmaceuticals Plc
• Takeda Pharmaceutical Company Limited
• Mapp Biopharmaceutical
• Collaborations Pharmaceuticals Inc.
• Emergent BioSolutions Inc.
• BioMarin and Sarepta Therapeutics
• Alkido Pharma
• Biofactura

A Full Report Overview

Key Segments Profiled in the Marburg Virus Disease Therapeutics Industry Survey

By Drug Classification:

• Antiemetic
• Nitro-glycerine
• Loperamide
• Antibiotics
• Others

By Route of Administration:

• Injectable
• Oral
• Parenteral

By End Users:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres
• Others

By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube